Your product is now available from Integrated DNA Technologies.
Many of the Swift products you have grown to love are now part of our new complete portfolio, xGen™ NGS. Through this new partnership we are pleased to offer you comprehensive next generation sequencing solutions.
xGen NGS—made for you.
Unsure of what products are available? Or, perhaps you’d like guidance on which products are compatible? If so, try our xGen NGS Solutions Builder Tool today.
Find Archer now at IDT!
All Archer information is now available on IDT’s website. You can view Archer assays alongside IDT’s xGen™ NGS portfolio to find the best next generation sequencing solution for your lab.
Confidently detect more with Archer NGS assay solutions for your solid tumor, blood cancer, immune profiling, and genetic disease research.
In this webinar, we will explain how IDT's hybridization capture solutions are assisting researchers with overcoming challenges associated with circulating tumor DNA (ctDNA) for minimal residual disease (MRD) research. You will also gain insights about the importance of minimal residual disease research, how it compares to traditional methods, and the impact it is making with the discovery of new biomarkers. We hope by bringing these studies into the spotlight, it will foster new collaborations and discoveries within oncology research.
In this webinar you will learn:
Published on: April 19, 2023